Know Cancer

or
forgot password

    • cancer clinical trials in alabaster, AL

    • STEPP: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-line Irinotecan Based Chemotherapy
    Research Site
    Alabaster, Alabama
    Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities, Colon Cancer, Colorectal Cancer
    A Rollover Study for Patients Who Received CP-675,206 in Other Protocols, to Allow the Patients Access to CP-675,206 Until This Agent Becomes Commercially Available or Development is Discontinued.
    Research Site
    Alabaster, Alabama
    Colorectal Neoplasms, Melanoma, Prostatic Neoplasms, Renal Cell Carcinoma, Neoplasms, Patients Who Have/Have Had Melanoma and Other Tumors
    First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
    Research Site
    Alabaster, Alabama
    Colorectal Cancer
    Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
    Research Site
    Alabaster, Alabama
    Recurrent Glioblastoma
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Alabaster, Alabama
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
    Research Site
    Alabaster, Alabama
    Cancer, Colon Cancer, Colorectal Cancer, Fever, Locally Advanced, Metastatic Colorectal Cancer, Neutropenia, Rectal Cancer
    TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
    Research Site
    Alabaster, Alabama
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
    Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma
    Research Site
    Alabaster, Alabama
    N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
    NOLAN: Naproxen or Loratadine and Neulasta
    Research Site
    Alabaster, Alabama
    Bone Pain in Stage I - III Breast Cancer
    Iressa Expanded Access Program (EAP)
    Research Site
    Alabaster, Alabama
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
    Research Site
    Alabaster, Alabama
    Non-Hodgkin's Lymphoma
    Iressa Versus Docetaxel (Taxotere)
    Research Site
    Alabaster, Alabama
    Non-Small-Cell Lung Carcinoma
    ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer
    Research Site
    Alabaster, Alabama
    Colorectal Cancer, Metastases
    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
    Research Site
    Alabaster, Alabama
    Breast Neoplasms, Neoplasms, Hormone-Dependent
    Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
    Research Site
    Alabaster, Alabama
    Squamous Cell Carcinoma of the Head and Neck
    GALLANT 5 Tesaglitazar Versus Metformin
    Research Site
    Alabaster, Alabama
    Diabetes Mellitus, Type 2
    GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
    Research Site
    Alabaster, Alabama
    Type 2 Diabetes Mellitus
    Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
    Research Site
    Alabaster, Alabama
    Non-metastatic Prostate Cancer
    Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
    Research Site
    Alabaster, Alabama
    Cancer, Carcinoma, Castrate-Resistant Prostate Cancer, Prostate Cancer, Tumors